RT Journal Article
T1 Single-agent daratumumab in patients with relapsed and refractory multiple myeloma requiring dialysis: results of a Spanish retrospective, multicentre study.
A1 Cejalvo, María J
A1 Legarda, Mario
A1 Abella, Eugenia
A1 Cabezudo, Elena
A1 Encinas, Cristina
A1 García-Feria, Ana
A1 Gironella, Mercedes
A1 Iñigo, Belén
A1 Martín, Jesús
A1 Ribas, Paz
A1 Ruíz, Mª Ángeles
A1 González, Yolanda
A1 Vicuña, Isabel
A1 Ramírez, Ángel
A1 Fernández, Pascual
A1 de la Rubia, Javier
K1 daratumumab
K1 dialysis
K1 multiple myeloma
K1 relapse
YR 2019
FD 2019-12-02
LK http://hdl.handle.net/10668/14782
UL http://hdl.handle.net/10668/14782
LA en
DS RISalud
RD Apr 9, 2025